Catalyst Wire Dossier Catalyst Wire Dossier

Epizon-701

EPN-701 · Epizon Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epizon-701, covering 2024-09-25 to 2024-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD) [Phase 2]

See pricing